Chronic Kidney Disease Anemia Management: What Should Be Done? | Zendy

Lynda A. Szczech | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Chronic Kidney Disease Anemia Management: What Should Be Done?

Author(s) -

Lynda A. Szczech

Publication year - 2011

Publication title -

blood purification

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.686

H-Index - 57

eISSN - 1421-9735

pISSN - 0253-5068

DOI - 10.1159/000321852

Subject(s) - intensive care medicine , observational study , harm , kidney disease , medicine , anemia , nephrology , randomized controlled trial , quality of life (healthcare) , disease management , disease , nursing , psychology , social psychology , parkinson's disease

A transition in the approach to anemia management in nephrology occurred when randomized trials demonstrated that higher hemoglobin targets do not result in better outcomes and may arguably cause harm. Contradicting the speculative conclusions drawn based on earlier observational data, this has resulted in hypotheses regarding the cause of these seemingly disparate but substantively similar messages. The renal community now must struggle with how to incentivize quality care and maximize patient quality of life while minimizing the real safety signal of which we are now aware.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research